Kaiming Tang

3.1k total citations · 1 hit paper
33 papers, 856 citations indexed

About

Kaiming Tang is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Kaiming Tang has authored 33 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Kaiming Tang's work include SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (11 papers) and Viral gastroenteritis research and epidemiology (4 papers). Kaiming Tang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (11 papers) and Viral gastroenteritis research and epidemiology (4 papers). Kaiming Tang collaborates with scholars based in Hong Kong, China and United States. Kaiming Tang's co-authors include Shuofeng Yuan, Jasper Fuk‐Woo Chan, Kwok‐Yung Yuen, Hin Chu, Ronghui Liang, Jianli Cao, Jian‐Piao Cai, Kelvin Kai‐Wang To, Cuiting Luo and Jinxia Zhang and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Kaiming Tang

32 papers receiving 844 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)

2020 400 citations Jasper Fuk‐Woo Chan, Shuofeng Yuan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kaiming Tang Hong Kong	14	505	153	119	110	100	33	856
Ronghui Liang China	13	507 1.0×	185 1.2×	154 1.3×	131 1.2×	104 1.0×	22	910
Jianli Cao China	12	470 0.9×	152 1.0×	142 1.2×	146 1.3×	96 1.0×	30	829
Laura Baseler United States	13	718 1.4×	286 1.9×	88 0.7×	184 1.7×	77 0.8×	18	1.2k
Hulda R. Jónsdóttir Switzerland	13	414 0.8×	103 0.7×	112 0.9×	129 1.2×	36 0.4×	23	808
Artur Szczepański Poland	12	466 0.9×	170 1.1×	50 0.4×	80 0.7×	87 0.9×	22	748
Yanhong Sun China	10	460 0.9×	128 0.8×	29 0.2×	77 0.7×	62 0.6×	25	664
Patrick J. Lenehan United States	15	436 0.9×	127 0.8×	70 0.6×	77 0.7×	77 0.8×	49	1000
Xihua Lian China	7	293 0.6×	123 0.8×	74 0.6×	67 0.6×	56 0.6×	18	553
María Florencia Gómez Castro Argentina	6	533 1.1×	167 1.1×	44 0.4×	74 0.7×	118 1.2×	8	814
Cuiting Luo China	8	365 0.7×	82 0.5×	106 0.9×	71 0.6×	87 0.9×	18	575

Countries citing papers authored by Kaiming Tang

Since Specialization

Citations

This map shows the geographic impact of Kaiming Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiming Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiming Tang more than expected).

Fields of papers citing papers by Kaiming Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiming Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiming Tang. The network helps show where Kaiming Tang may publish in the future.

Co-authorship network of co-authors of Kaiming Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiming Tang. A scholar is included among the top collaborators of Kaiming Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiming Tang. Kaiming Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ye, Zi‐Wei, Chon Phin Ong, Kaiming Tang, et al.. (2025). A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3a. EBioMedicine. 114. 105662–105662.

Au, Man Ting, Kaiming Tang, Wei Wang, et al.. (2024). Blockade of endothelin receptors mitigates SARS-CoV-2-induced osteoarthritis. Nature Microbiology. 9(10). 2538–2552. 2 indexed citations

Au-Yeung, Rex, Kaiming Tang, Degong Ruan, et al.. (2024). SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids. Scientific Reports. 14(1). 8781–8781. 2 indexed citations

Liang, Ronghui, Zi‐Wei Ye, Zhenzhi Qin, et al.. (2024). PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitness. Nature Communications. 15(1). 2144–2144. 11 indexed citations

Tang, Kaiming, Guilin Chen, Yubin Xie, et al.. (2024). An enhanced broad-spectrum peptide inhibits Omicron variants in vivo. Cell Reports Medicine. 5(2). 101418–101418. 5 indexed citations

Cheng, Tianfan, Kaiming Tang, Hongyan Li, et al.. (2024). Integration of metalloproteome and immunoproteome reveals a tight link of iron-related proteins with COVID-19 pathogenesis and immunity. Clinical Immunology. 263. 110205–110205. 3 indexed citations

Yuan, Shuofeng, Fan Xiao, Hongyan Li, et al.. (2023). Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity. Chemical Science. 14(38). 10570–10579. 9 indexed citations

Qin, Bo, Ziheng Li, Kaiming Tang, et al.. (2023). Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target. Nature Communications. 14(1). 3999–3999. 16 indexed citations

Du, Qiaohui, Ronghui Liang, Meiling Wu, et al.. (2023). Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for the treatment of COVID-19. Journal of Advanced Research. 62. 273–290. 4 indexed citations

10.

Wen, Kun, Jian‐Piao Cai, Xiaojuan Zhang, et al.. (2023). Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant. Frontiers in Cellular and Infection Microbiology. 13. 1213806–1213806. 3 indexed citations

11.

Ong, Chon Phin, Zi‐Wei Ye, Kaiming Tang, et al.. (2022). Comparative analysis of SARS‐CoV‐2 Omicron BA.2.12.1 and BA.5.2 variants. Journal of Medical Virology. 95(1). e28326–e28326. 19 indexed citations

12.

Ye, Zi‐Wei, Kaiming Tang, Chon Phin Ong, et al.. (2022). Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines. International Journal of Biological Sciences. 18(12). 4781–4791. 5 indexed citations

13.

Ye, Zi‐Wei, Chon Phin Ong, Kaiming Tang, et al.. (2022). Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals. Cellular and Molecular Immunology. 19(5). 588–601. 29 indexed citations

14.

Ruan, Degong, Zi‐Wei Ye, Shuofeng Yuan, et al.. (2022). Human early syncytiotrophoblasts are highly susceptible to SARS-CoV-2 infection. Cell Reports Medicine. 3(12). 100849–100849. 18 indexed citations

15.

Liao, Qiuying, Shuofeng Yuan, Jianli Cao, et al.. (2021). Inhaled Dry Powder Formulation of Tamibarotene, a Broad‐Spectrum Antiviral against Respiratory Viruses Including SARS‐CoV‐2 and Influenza Virus. Advanced Therapeutics. 4(7). 17 indexed citations

16.

Wen, Lei, Kaiming Tang, Kenn Ka‐Heng Chik, et al.. (2021). In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor. International Journal of Biological Sciences. 17(6). 1555–1564. 11 indexed citations

17.

Cao, Jianli, Gang Lu, Lei Wen, et al.. (2021). Severe fever with thrombocytopenia syndrome virus (SFTSV)-host interactome screen identifies viral nucleoprotein-associated host factors as potential antiviral targets. Computational and Structural Biotechnology Journal. 19. 5568–5577. 9 indexed citations

18.

Yuan, Shuofeng, Jasper Fuk‐Woo Chan, Chris Chun-Yiu Chan, et al.. (2020). Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacological Research. 159. 104960–104960. 47 indexed citations

19.

Aslam, Muhammad, Xiaojuan Liu, Hong Du, et al.. (2020). Impact of Pb on Chlamydomonas reinhardtii at Physiological and Transcriptional Levels. Frontiers in Microbiology. 11. 1443–1443. 29 indexed citations

20.

Zhu, Wenqing, Lina Xu, Wanqing Chen, et al.. (2019). Enhanced corrosion resistance of zinc-containing nanowires-modified titanium surface under exposure to oxidizing microenvironment. Journal of Nanobiotechnology. 17(1). 55–55. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact